LATEST NEWS

LJI researcher delves into what triggers type 1 diabetes
A Q&A with Estefania Quesada-Masachs, M.D., Ph.D.
No one knows exactly what triggers type 1 diabetes, but researchers at La Jolla Institute for Immunology have uncovered some fascinating clues.
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
"To prevent and treat the disease, it is vital to understand how the immune cells attack the body's own insulin-producing beta cells"
New LJI discovery could help explain patterns of cell death in many autoimmune diseases